@article{ATM20161,
author = {Xavier Roblin and Mathurin Flamant},
title = {DIAMOND study: an additional evidence of the interest of being proactive in IBD},
journal = {Annals of Translational Medicine},
volume = {6},
number = {13},
year = {2018},
keywords = {},
abstract = {The DIAMOND study is a multicenter, randomized, open-label study comparing adalimumab (ADA) with ADA plus azathioprine (AZA) in immunosuppressant-naïve CD patients (1).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/20161}
}